Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer
Status:
Unknown status
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The present study is a multicentric randomized phase III trial designed to assess whether
overall survival and quality of life are improved in patients with asymptomatic colon cancer
and unresectable SLM treated with resection of the PT followed by chemotherapy versus
chemotherapy alone.
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborators:
Federation Francophone de Cancerologie Digestive GERCOR - Multidisciplinary Oncology Cooperative Group Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) UNICANCER